Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
pfizer
san diego blog main
san diego top stories
abbvie
akcea therapeutics
allergan aesthetics
alnylam pharmaceuticals
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
biotech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
What
drug
2
×
way
2
×
acquisitions
alnylam
approves
biggest
bio
build
buy
cells
ceo
company’s
daniel
debut
dyne’s
ema
employ
europe
fda
follows
gene
gilead
harmful
hits
interference
make
medicine
method
microbiome
moves
mute
openly
o’day
pipeline
protein
rna
rnai
roundup
sciences
scores
Language
unset
Current search:
way
×
drug
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
